Geriatric Assessment Reveals Actionable Impairments in Hematopoietic Stem Cell Transplantation Candidates Age 18 to 80 Years.

Autor: Lew MV; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina., Ren Y; Duke Cancer Institute Biostatistics Shared Resources, Durham, North Carolina., Lowder YP; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina., Siamakpour-Reihani S; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina., Ramalingam S; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina., Romero KM; Duke University School of Medicine, Durham, North Carolina., Thompson JC; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina., Bohannon LM; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina., McIntyre J; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina., Tang H; Duke University School of Medicine, Durham, North Carolina., Van Opstal J; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina; Faculty of Medicine, KU Leuven, Leuven, Belgium., Johnson E; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina., Cohen HJ; Claude D. Pepper Older Americans Independence Center, Center for the Study of Aging and Human Development, Duke University Medical Center, Durham, North Carolina., Bartlett DB; Claude D. Pepper Older Americans Independence Center, Center for the Study of Aging and Human Development, Duke University Medical Center, Durham, North Carolina; School of Biosciences and Medicine, University of Surrey, Surrey, United Kingdom., Pastva AM; Claude D. Pepper Older Americans Independence Center, Center for the Study of Aging and Human Development, Duke University Medical Center, Durham, North Carolina; Department of Orthopedic Surgery, Division of Physical Therapy, Duke University Medical Center, Durham, North Carolina., Morey M; Claude D. Pepper Older Americans Independence Center, Center for the Study of Aging and Human Development, Duke University Medical Center, Durham, North Carolina; Geriatric Research, Education and Clinical Center, Durham VA Healthcare System, Durham, North Carolina., Hall KS; Claude D. Pepper Older Americans Independence Center, Center for the Study of Aging and Human Development, Duke University Medical Center, Durham, North Carolina; Geriatric Research, Education and Clinical Center, Durham VA Healthcare System, Durham, North Carolina., Smith P; Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina., Peters KB; Departments of Neurology and Neurosurgery, The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina., Somers TJ; Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina., Kelleher S; Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina., Smith SK; School of Nursing, Duke University Medical Center, Durham, North Carolina., Wischmeyer PE; Department of Anesthesiology, Duke University Medical Center, Durham, North Carolina., Lin PH; Duke Molecular Physiology Institute, Duke University School of Medicine, Durham, North Carolina., Wood WA; Division of Hematology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Thorpe G; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina., Minor K; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina., Wiggins K; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina., Hennig T; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina., Helms T; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina., Welch R; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina., Matthews B; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina., Liu J; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina., Burleson J; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina., Aberant T; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina., Engemann AK; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina., Henshall B; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina., Darby M; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina., Proch C; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina., Dellascio M; Duke Health Department of Physical Therapy and Occupational Therapy, Durham, North Carolina., Pittman A; Duke Health Department of Physical Therapy and Occupational Therapy, Durham, North Carolina., Suminguit J; University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Choi T; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina., Gasparetto C; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center, Durham, North Carolina., Long GD; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center, Durham, North Carolina., Lopez RD; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina., Sarantopoulos S; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina., Horwitz ME; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center, Durham, North Carolina., Chao NJ; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center, Durham, North Carolina., Sung AD; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina; Claude D. Pepper Older Americans Independence Center, Center for the Study of Aging and Human Development, Duke University Medical Center, Durham, North Carolina. Electronic address: anthony.sung@duke.edu.

Publikováno v: Transplantation and cellular therapy [Transplant Cell Ther] 2022 Aug; Vol. 28 (8), pp. 498.e1-498.e9. Date of Electronic Publication: 2022 May 17.